Now Serum Institute’s billionaire boss Adar Poonawalla has chimed in on the debate with his tongue-in-cheek tweet, agreeing ...
The current market surge is fueling excitement among investors, who are keen to spot the next big gainers. With the bull run ...
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has received a positive ...
Federal prosecutors have disclosed the discovery of additional criminal conduct involving New York City Mayor Eric Adams, ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
CD Bioparticles announces its comprehensive portfolio of products for the isolation and extraction of Exosome DNA & RNA. NEW YORK, NY, UNITED ...
The cryptocurrency market continues to surge with innovation and potential, creating opportunities that redefine global ...
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-Mâ„¢ adjuvant, today announced progress in Q4 2024 advancing its corporate growth strategy through its ...
Santhera Pharmaceuticals (SIX: SANN) announces that Idorsia Pharmaceuticals has entered into a royalty monetization agreement with the R-Bridge Healthcare Fund in relation to AGAMREE® (vamorolone).
Company on track to report topline data in first half of 2025Positive preliminary data from all five single ascending dose (SAD) cohorts ranging ...
MELBOURNE, Australia and LIÈGE, Belgium, Jan. 16, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has received a positive ...
Updating peak systemic mastocytosis franchise revenue opportunity to $4 billion, catalyzed by strong AYVAKIT® (avapritin ...